MedTrace Logo

Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome

NCT01705925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2019-05-06

No results posted yet for this study

Summary

The purpose of the study is to provide comprehensive follow-up in patients with Long QT Syndrome (LQTS) and gain additional information regarding genotype-phenotype correlation and effective management and treatment options.

Conditions

  • Long QT Syndrome

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Principal Investigators

  • Mitchell Cohen, M.D. · Pediatrix

  • Arnold Fenrich, MD · Pediatrix

  • Reese Clark, MD · Pediatrix

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705925 on ClinicalTrials.gov